Dr Jean Abraham Cambridge University Hospitals NHS Foundation Trust
Dr Anne Armstrong The Christie NHS Foundation Trust
Dr Anne Armstrong graduated from Bristol University in 1995. She specialises in Medical Oncology, training at the Christie Hospital, taking up a Consultant post in 2007 to specialise in Breast Cancer. She has a particular interest in breast cancer in young women, including fertility preservation and pregnancy as well as survivorship issues. Also is actively involved in clinical and laboratory-based research, with a particular focus on immunotherapy, having completed a PhD at the University of Manchester in 2002. Dr Armstrong sits on the NCRI Breast Clinical Studies Group and is Co-Chair of the NCRI Breast Symptom Management Subgroup. she was the Clinical Lead for NICE for the 2018 update of the Early and Locally advanced breast cancer guideline and am currently the Lead Developer for the RCOG/ABS guideline for Pregnancy and Breast Cancer.
Chris Atkin Sirius Medical
Mr Matthew Barber Edinburgh Breast Unit
Matthew Barber is a Consultant Breast Surgeon in Lothian and chair of the South East Scotland Breast Cancer Network. He graduated from the University of Glasgow and trained in Edinburgh and Manchester. He has interests in the organisation of breast services, training in breast surgery and outcomes of implant-based breast reconstruction.
Professor John Benson Addenbrooke’s Hospital, Cambridge
Professor Benson is a Consultant Breast Surgeon at Addenbrooke’s Hospital, Cambridge, Associate Lecturer, University of Cambridge and Visiting Professor, School of Medicine, Anglia Ruskin University, Cambridge, UK. He has published widely in the field of breast diseases with authorship of more than 160 papers and has written/edited 7 books on breast cancer/reconstructive surgery (ranked in the top 0.084% of the world’s breast cancer experts). He is a former member of the Planning Committee for the San Antonio Breast Cancer Symposium (2013 – 2015) and was a Trustee/member of the Executive Board of ABS until demitting from office in 2021.
Mr Pud Bhaskar North Tees and Hartlepool NHS Trust
Pud Bhaskar is a Consultant General and Oncoplastic Breast Surgeon at North Tees and Hartlepool NHS Trust. He graduated from the University of Madras with MB BS and Masters in General Surgery. He completed a MD in Growth factors and their influence on cancer in Acromegaly patients at the University of Newcastle. He completed his higher surgical training in the Northern Deanery and undertook a TIG fellowship in Chelmsford (St Andrew’s centre for Plastic Surgery and Burns). He took up his consultant post in 2003 and has contributed to research in tissue and plasma expression of mammoglobin A and growth factors in human breast cancer pathology, and Adipose derived regenerative cells in tissue repair. He has a particular interest and has contributed significantly to trials involving ADM based breast reconstructions, Lipomodelling and autologous fat banking.
Dr Indrani Bhattacharya Addenbrooke's Hospital
Dr Indrani Bhattacharya was appointed as a Consultant Clinical Oncologist in Cambridge University Hospitals NHS Foundation Trust in August 2020. She has expertise in technical breast radiotherapy and clinical trials radiotherapy quality assurance as well as delivery of systemic therapies for breast cancer patients. She completed a 3-year CRUK clinical trials fellowship and PhD in The Institute of Cancer Research's Clinical Trials and Statistics Unit working within the portfolio of breast radiotherapy trials including the IMPORT and PRIMETIME studies. She has an interest in risk-adapted breast radiotherapy, delivering new radiotherapy technologies, drug-RT combinations and improving patient-reported outcomes (PRO) and is the PRO lead in the UK PARABLE breast proton study.
Miss Rachel Bright-Thomas Worcestershire Acute NHS Trust
Rachel was appointed as a Consultant Oncoplastic Breast Surgeon in Worcester in 2006. Over the last 16 years she has been MDT Lead and Breast Clinical Lead within the Trust. She has a long history in surgical education having been college tutor and MRCS examiner in the past. She is now an Area Training Programme Director for General Surgery in the West Midlands, the Breast Lead and Bullying and Harassment Lead for the General Surgery Specialty Advisory Committee and sits on the ABS Education and Training Committee.
Mr Arjuna Brodie
Mr Henry Cain Newcastle Upon Tyne Hospitals NHS Trust
Mr Henry Cain is a Consultant Surgeon in Newcastle upon Tyne. His interests include use of multi-gene assays guiding Neo-Adjuvant therapy. CI for the PRE-DX study.
Miss Leena Chagla St Helen's & Knowsley Teaching Hospital NHS Trust
Miss Leena Chagla is the President elect of the Association of Breast Surgery and past-President of the Liverpool and Northwest Society of Surgeons. She heads the breast unit at St Helens and Knowsley Teaching Hospitals which is actively involved in clinical innovation and trials. She continues to publish regularly in peer reviewed journals. Leena qualified from Grant Medical College, Mumbai, with a gold medal in Surgery. Whilst in India, she trained at the Sir JJ Hospital and at the Tata Memorial Cancer Centre. Her passion for surgical oncology developed in those formative years. She is a popular speaker both nationally and internationally and is involved in the development of guidelines for the management of breast cancer. She is passionate about MDT working and she launched the Anti-bullying Campaign (#CoreItOut) for ABS in alliance with RCSEd. She represented ABS on the pathology Big 18 and the organising committee of Symposia Mammographicum. Leena was instrumental in setting up the International Forum at ABS with a view to sharing good practice globally. She is committed to improving and standardising Breast cancer care through education and training. She is an Educational Supervisor for the National Oncoplastic Fellow and she is a Professional Clinical Advisor for screening to Public Health England. Outside of work Leena is a keen sportswoman having played water-polo for Maharashtra, Liverpool and the Northern Counties at the highest level.
Dr Nur Amalina Che Bakri Imperial College London
Miss Carol-Ann Courtney Royal Derby Hospital
Carol-Ann Courtney is a Consultant Oncoplastic Breast Surgeon based at the Royal Derby Hospital since 2007. She is the East Midlands representative to ABS. She has an interest in medical education and has been a tutor on the MS Oncoplastics degree offered by the University of East Anglia since it's inception and serves as the Locally Employed Doctors Tutor in her Trust.
Professor Ramsey Cutress University of Southampton & University Hospitals Southampton
Ramsey Cutress is Professor of Breast Surgery and Consultant Surgeon at the University of Southampton and University Hospital Southampton. Ramsey was a member of the writing group for the NICE Early and Locally Advanced Breast Cancer Guideline (NG101) and the ABS BAPRAS Oncoplastic Breast Reconstruction Guidelines, and he is co-director of the ABS Advanced Skills in Breast Disease Management Course. His clinical research interests include breast cancer in young women as a member of the POSH study research team and the investigation of patient and host determinants of breast cancer outcomes including genetic predisposition, immunological and lifestyle factors. He is currently involved in various national research studies and clinical trials including the EndoNET HTA funded trail of neo-adjuvant endocrine therapy. He is Chair of the Academic and Research Committee of the Association of Breast Surgery (ABS) and breast sub-specialty editor for the Annals of the Royal College of Surgeons.
Professor Jack Cuzick Wolfson Institute of Population Health, Queen Mary University of London
Jack Cuzick is the Director of the Wolfson Institute of Preventive Medicine in London and the head of its Centre for Cancer Prevention. He is John Snow Professor of Epidemiology at Queen Mary, University of London. He holds a PhD in Mathematics and has previously worked at Oxford University and Columbia University, New York. His current interests are in prevention and screening. He is currently Chairman of the International Breast Cancer Intervention Study (IBIS) Steering Group and the ATAC adjuvant treatment trial. He has worked extensively in breast cancer and was the first to report the effect of tamoxifen on contralateral tumours as an indicator of its potential chemopreventive role, and also has demonstrated that a change in mammographic breast density on endocrine treatment is a biomarker for its effectiveness. In the IBIS-I trial he recently demonstrated that the preventive effect of 5 years of tamoxifen lasts for at least 20 years. He is also involved in studies on the use of HPV assays for cervical screening, the use of flexible sigmoidoscopy for colorectal cancer screening and markers for the behaviour of early prostate cancer. He was awarded CBE in 2017, and is a Fellow of the Royal Society, Academy of Medical Sciences and the Royal Statistical Society.
Miss Isabella Dash North Bristol NHS Trust
Isabella qualified from the University of Southampton and then undertook her surgical training in the Severn Deanery. She was the South West regional representative and subsequently Mammary Fold representative for ASiT. Before her CCT, she undertook an oncoplastic fellowship in Perth, Western Australia. Isabella started her Oncoplastic Consultant position at North Bristol NHS Trust in 2019, where she enjoys being the Educational Lead. She is currently the South West representative for the ABS. She is faculty for the Leadership and Management module for the University of East Anglia Oncoplastic Breast Surgery Masters. She has just returned to work from maternity leave.
Miss Marianne Dillon Swansea Bay University Health Board
Dr David Dodwell Nuffield Department of Population Health, University of Oxford
David Dodwell is a Consultant in Clinical Oncology and Senior Clinical Research Fellow at the University of Oxford and Oxford University Hospitals NHS Trust. He works within the Early Breast Cancer Trialists' Collaborative Group.
Dr Olivia Donnelly North Bristol NHS Trust
Dr Olivia Donnelly is a Consultant Clinical Psychologist at North Bristol NHS Trust. Her background is in the psychology of physical health, and as well as her work supporting patients within breast care and cancer services, she leads the Trust's Staff Psychology Team. She has a particular interest in practical, values-based approaches to promoting wellbeing within individuals, teams, and across healthcare organisations, based on the foundation that ‘resilience is between us, not just within us’. You can follow Olivia on twitter @Dr_O_Donnelly
Miss Julie Doughty Gartnavel General Hospital
Associate Professor Sue Down James Paget University Hospital
Sue Down is a Consultant Oncoplastic Breast Surgeon at James Paget University Hospital, and an Associate Professor at the University of East Anglia. She graduated from the University of Manchester with MB BCh awards and a BSc in Biomedical Science. She completed a PhD in Cancer Studies at the University of Birmingham and higher surgical training in the East of England. She undertook a TIG fellowship post in Birmingham prior to taking up her consultant post in 2013. Sue is the incoming Chair of the ABS Education and Training Committee. She currently directs four international Masters and PG Dip courses in oncoplastic and aesthetic breast surgery at the University of East Anglia, and has strong educational links with breast surgeons globally.
Mr Ken Dunn
Ken Dunn initially trained in London and was a trainee surgeon in a number of burns and plastic surgery units in England, including East Grinstead, the Accident Hospital in Birmingham and the Odstock Unit in Salisbury. He was a Consultant in Manchester, England from 1996 until clinical retirement in 2018 prior to which he was the Director of the Manchester Burn Services and Clinical Lead for the Manchester Burns and Plastic Surgery Service and lead for the Complex Wound Service. He was also the Associate Medical Director for Clinical Informatics/Patient Level Costing. Nationally, he is a past Chairman of the British Burn Association and the National Burn Care Review Committee (2001). He is currently the Medical Director of the International Burn Injury Database (iBID: www.ibidb.org) and joint author of the Burn Care Standards (iBCS: www.burnstandards.org) 2004. He is also the current Lead Chair of the joint Expert Working Groups of the National Casemix Office at NHS Digital, which is responsible for the coding and classification of all NHS activity and the national GIRFT clinical lead for Plastics Surgery, Hand Surgery and Burn Care (www.gettingitrightfirsttime.co.uk). He also has several roles within the National Wound Care Strategy Programme (https://www.ahsnnetwork.com/about-academic-health-science-networks/national-programmes-priorities/national-wound-care-strategy-programme).
Dr Ahmed Ezzat Imperial College London
Miss Rachel Foster St Helen's and Knowsley NHS Trust
Mr Ashu Gandhi Manchester University NHS Foundation Trust
Ashu Gandhi works as a Consultant Breast Surgeon in Manchester. He has previously served the ABS in a variety of roles and is current Chair of the NHS BSP Screening Audit Committee.
Miss Clare Garnsey Bolton NHS Foundation Trust
Miss Toral Gathani Nuffield Department of Population Health, University of Oxford and Oxford University Hospitals NHS Foundation Trust
Toral Gathani is a Senior Clinical Research Fellow in the Cancer Epidemiology Unit of the Nuffield Department of Population Health, University of Oxford and Consultant Oncoplastic Breast Surgeon at Oxford University Hospitals NHS Foundation Trust. She studied Medicine at the University of St Andrews and Guy’s and St Thomas’ Medical School graduating in 1999 with Honours. She undertook her surgical training in London and at the Nottingham Breast Institute. She is a member of the Clinical Advisory Panel for Cancer Research UK and the Academic and Research Committee for the Association of Breast Surgery. She was appointed Senior Research Fellow at Green Templeton College at the University of Oxford in 2019. The Royal College of Surgeons of England awarded her a Hunterian Professorship in 2022 for her work on ethnicity and breast cancer. Toral was a research fellow in the Cancer Epidemiology Unit at Oxford in 2003-2006 where she undertook the research for her MD thesis. She continued to develop her interest in epidemiology during her specialist surgical training and in addition to her UK based work, she has spent time working in India in a research and clinical capacity. She is a past recipient of a British Medical Association Humanitarian Award for public health related work in Assam, India. Her main research interests are in the intersection of ethnicity and breast cancer in women in the UK and of breast cancer as a global health challenge.
Dr Kirakoula Georgas Royal Surrey County Hospital
Associate Professor Amit Goyal University Hospitals of Derby and Burton NHS Foundation Trust
Amit Goyal is a Consultant Oncoplastic Breast Surgeon & Associate Professor at the Royal Derby Hospital, UK. His research is focused on axillary management in breast cancer. He is the Chief Investigator of the largest breast cancer surgical trials addressing the role of axillary treatment in the UK – POSNOC and ATNEC.
Miss Lis Grimsey East Sussex Healthcare NHS Trust
Lis Grimsey has been a Macmillan Consultant Nurse at East Sussex Healthcare NHS Trust for 20 years. Lis was the Nurse Trustee for ABS from 2012-2017. I am now a member of the International Committee. In 2019, Lis went to Zimbabwe with the International Committee to teach a group of very enthusiastic nurses. She has co-written an online course for nurses in countries of low and middle income.
Dr David Hakim Imperial College Healthcare Trust
Dr Victoria Harmer Imperial College Healthcare NHS Trust
Dr Victoria Harmer, who qualified with an award for distinction in practice, is Consultant nurse (breast) and lead nurse for the breast screening and symptomatic services at Imperial College Healthcare NHS Trust. She has published widely, and acted as medical adviser for radio, television and film. She has worked with Marks and Spencer designing swimwear for the post mastectomy body, is Trustee for 'Against Breast Cancer' charity, on the Medical Advisory Board for 'CoppaFeel!' charity, Deputy Chair for 'Europa Donna UK' and a member of the ABS International Forum, joining the group who went to Nairobi to teach in 2019.
Mrs Janet Hicks
Janet Hicks was a Breast Care Nurse for over 20 years working in Southport and Ormskirk NHS Trust and latterly at St Helens and Knowsley Hospital. A member of the International Committee, in 2019 Janet went to Zimbabwe with other members to teach a group of nurses. She has co-written an online course for nurses in low and middle-income countries.
Mrs Katy Hogben Imperial College Healthcare NHS Trust
Mrs Katy Hogben graduated in London in 1993 and trained in the south west Thames region in general surgery. She obtained a national oncoplastic training fellowship in 2005 and commenced her consultant post at Imperial College Healthcare NHS Trust in 2006. She is lead surgeon of the west of London breast screening unit. She is meetings secretary of the Association of Breast Surgery UK. She is also training programme director for higher surgery in West London.
Professor Chris Holcombe Liverpool University Hospitals NHS Foundation Trust
Chris is a Consultant Oncoplastic Breast Surgeon at the Liverpool University Hospitals Foundation Trust and President of the Association of Breast Surgery.
Mrs Sue Holcombe Liverpool University Hospital Foundation Trust
Trained at the Royal Free Hospital 1976-1979. and has worked in breast care since 1994. Went on to complete an MA in Practitioner development in Manchester. Worked as an Advanced Breast Nurse Practitioner in the breast unit at the Royal Liverpool Hospital. Currently an ABS Nurse Trustee.
Professor Kieran Horgan Leeds Teaching Hospitals
Breast surgeon. Co-initiator of National Oncoplastic Breast Surgery Training Fellowship Scheme. Core Faculty for national sentinel node training and validation. Committed trials. Author/co-author of 150 peer reviewed papers. Ex President and Hon Sec of ABS. Previous Chair NCIN Breast Cancer Sub-specialty Group. Extern for MS Oncoplastic Breast Surgery UEA. Surgery Lead - Chair Clinical Steering Group NABCOP 2014-date.
Ms Jennifer Hu St Bartholomew's Hospital
Ms Jennifer Hu has been an Oncoplastic and Reconstruction Breast Consultant at Barts NHS Trust since 2010. In 2013, she became the Lead Screening Surgeon for the Central and East London Breast Screening Service and for 7 years from 2014 was the Clinical Lead of Breast Services at Barts. Since 2015, she has been the Training Program Director for General Surgery in North Central and East London. Ms Hu undertook surgical training mainly in London after graduating from the United Medical and Dental Schools of Guy’s and St Thomas’ Hospital. She also has a PhD in the treatment of breast cancer, using a novel oncolytic virus.
Alex Humphreys Gloucestershire NHS Foundation Trust
Alex is currently Vice-Chair of the Mammary fold committee and an ST8 in the South West. She has always had an interest in training and education and has previously held the post of lead surgical trainee for Health Education South West, having completed a fellowship in Simulation and Human Factors training.
Miss Tracey Irvine Royal Surrey County Hospital NHS Foundation Trust
Tracey studied at Queens’ College Cambridge and then did her clinical training at Guys and St Thomas’ Hospital, London. She did her surgical training in the South East Thames area before obtaining a National Oncoplastic Fellowship in Manchester. She has been a Consultant Oncoplastic Surgeon in Guildford since 2009. Tracey has a special interest in oncoplastic breast conservation, neoadjuvant chemotherapy and management of the axilla and runs the Guildford gene carrier clinic for patients in the KSS region. In 2015 she was awarded the Murray Brennan Scholarship by the American College of Surgeons and spent two months in the major cancer centres in the US. Since 2017 she has been Senior Clinical advisor for the breast Getting it Right First Time (GIRFT) programme.
Miss Charlotte Ives Royal Devon and Exeter NHS Trust
Miss Charlotte Ives is currently a Consultant Oncoplastic Breast Surgeon at the Royal Devon and Exeter NHS Foundation Trust. Prior to this she was a national oncoplastic TIG fellow. Interests include research and development: she is a member of the ABS Academic and Research committee, chair of the Site Specific Group for Breast Surgery (Peninsula), clinical audit lead for breast surgery at RD&E, as well as acting as principal investigator at her trust for the MARECA, ENDONET and other studies. Education is also a strong interest and she is currently Education Specialty Lead for Breast Surgery and a Professional Development Tutor with the University of Exeter Medical School.
Miss Swati Jha Sheffield Teaching Hospitals NHS Foundation Trust
Miss Jha is a Consultant Gynaecologist and subspecialist in Urogynaecology working at Sheffield Teaching Hospitals. She is research active and has over 140 publications and several successful grants. She has written a book on Medicolegal issues in Obstetrics and Gynaecology with 2 more in the pipeline. She is on the editorial board of the TOG journal (RCOG CPD journal ) and Best Practice in O and G. She is a spokesperson to the RCOG on pelvic floor health and served as Chair of the British Society of Urogynaecology till November 2021.
Ms Natasha Jiwa King George Hospital
Natasha is the current Chair of the Mammary Fold. She is an ST7 trainee in the North East Thames Deanery and is completing her PhD in the early detection of breast cancer through the interrogation of nipple aspirate fluid. She is passionate about Global Surgery and in her previous role as Vice President of the surgical charity Motec Life-UK, made biannual visits to West Africa to teach, assist in theatre and run breast clinics.
Baroness Helena Kennedy QC IBHRI
Baroness Helena Kennedy QC is one of the UK's most distinguished lawyers. She has practiced at the Bar for over 40 years in the field of criminal law and has conducted many of the leading cases in those years, including the Balcombe Street Siege, the Brighton bombing trial, the Guildford Four Appeal, Michael Bettany Espionage case, the Jihadist fertiliser bomb plot and the transatlantic bomb plot. She has championed law reform for women, especially relating to sexual and domestic violence and developed the defence of Battered Women's syndrome in the British courts. She has chaired the British Council and the UK Human Genetics Commission. She has been a member of the House of Lords for over 20 years, where she chaired The European Union Sub-committee on Justice issues. She is the President of Justice, the British arm of the International Commission of Jurists. She is a member of the Microsoft Technology and Human Rights Advisory Council and a member of The British Academy. She has stepped down as Principal of Mansfield College, Oxford and become the new Chancellor of Sheffield Hallam University. Helena is currently Director of the Institute of Human Rights at the global lawyers organisation, The International Bar Association. She is working across the world on promoting and protecting human rights.
Ms Lucy Khan Forth Valley Royal Hospital
Ms Lucy Khan trained in the Edinburgh Breast Unit under Prof Mike Dixon OBE before undertaking an oncoplastic fellowship at Frimley Park Hospital in Surrey. She initially took up a post as a consultant at Mid Cheshire Hospitals NHS Trust before moving back to Scotland where she is a consultant oncoplastic and reconstructive surgeon in NHS Forth Valley. She has a busy symptomatic and cosmetic private practice based in Edinburgh and Stirling and is a member of the ABS Aesthetic Committee.
Mr Ilyas Khattak Ysbyty Gwynedd & Llandudno Hospital Betsi Cadwaladr University Health Board North Wales
My Khattak is a Consultant Oncoplastic Breast Surgeon working in sunny North West Wales (Ysbyty Gwynedd, Betsi Cadwaladr University Health Board). He graduated from the University of Liverpool in 1999, and undertook his training at the Mersey Deanery and North West prior to moving to Wales in 2013. Mr Khattak is the ABS representative for Wales and sits on the Clinical Practice and Standards Committee.
Mr Baek Kim St. James's University Hospital, Leeds
Mr Kim is a Consultant Oncoplastic Breast Surgeon at the Leeds Breast Unit. HE trained in the Yorkshire Deanery and completed the National Oncoplastic TIG fellowship in Newcastle. He was awarded an MD degree at the University of Leeds for a translational research project investigating potential biomarkers in breast cancer patients treated with neoadjuvant systemic therapy. He is a member of the ABS academic and research committee and currently leading on the delivery of the MARECA study.
Dr Anna Kirby Royal Marsden NHS Foundation Trust
Dr Anna Kirby is a Consultant Clinical Oncologist in the UK specialising in the treatment of patients with breast cancer. She leads research into novel breast radiotherapy techniques at The Royal Marsden and Institute of Cancer Research, London. She is Technical Radiotherapy Lead for the UK Breast Proton Trial (PARABLE), Chief Investigator of the UK HeartSpare studies, Chief Clinical Co-ordinator of the IMPORT breast radiotherapy trials, and Breast Lead Investigator on the CORE trial evaluating the role of stereotactic radiotherapy in treating oligometastatic disease. Current research interests include investigating the roles of proton beam therapy & MR Linac technology in treating breast cancer. She will become President of the European Society for Radiotherapy and Oncology (ESTRO) in May 2022.
Mrs Rebekah Law Royal Marsden NHS Foundation Trust
Rebekah Law graduated in medicine from St George's Hospital Medical School in 2010. From 2019-2021 she undertook an MD(res) within the Breast Cancer Research Division of the Institute of Cancer Research of London, UK. Her research focused on primary breast cancer prevention, under the supervision of Ms Jennifer Rusby and Ms Katherine Krupa. She now holds an honorary clinical research fellowship at the Royal Marsden Hospital as she is in the write-up phase of her MD and has returned to general surgical training at Croydon University Hospital.
Professor Andreas Makris Mount Vernon Cancer Centre
Consultant Clinical Oncologist at the Mount Vernon Cancer Centre and Honorary Professor at Warwick University. Co-Chair of the UK Breast Cancer Group and Chair of the Inter-disciplinary Breast cancer Symposium. Trustee of Breast Cancer Now.
Mr Yazan Masannat Aberdeen Royal Infirmary
Yazan Masannat, MBBS, MRCS(Ed), MRCSI(Dublin), DBRM(UAB), FEBS(Breast Surgery), FRCSEd(Gen Surgery), MD(Leeds) Yazan is a Consultant Oncoplastic Breast Surgeon based at Aberdeen Royal Infirmary in the Northeast of Scotland and has been recently appointed as an Associate Post Graduate Deans for Quality by NHS Education for Scotland (NES). He is an Honorary Senior Clinical Lecturer at the University of Aberdeen and an E-Tutor at the MS Oncoplastic Breast Surgery Program run by the University of East Anglia. He sits on the Education and Training committees of both the Association of Breast Surgery (ABS) and at the European Society of Surgical Oncology (ESSO) and has been recently elected as a member of the Board of Trustees of the ABS. He is the Communications Lead and part of the Executive Group at the iBRA-Net and an Examiner at the European Board of Surgical Oncology and European Board of Breast Surgery (UEMS) Yazan has more than 30 publications and has been awarded numerous research grants including the prestigious NRS Fellowship award by the Chief Scientist Office in Scotland to continue research on Novel MRI techniques in Breast Cancer with the Team at the University of Aberdeen. Education is Yazan’s main passion, and he enjoys networking with people from across the world. He has created www.iBreastBook.com which is a free online resource with contributions from many of the leading Breast and Plastic surgeons across the world. During the Coronavirus Lockdown he started the iBreastBook Webinar series with the support of colleagues from across the world. These webinars have been a huge international success, with more than 25 webinars up to March 2022 with most webinars attracting more than 1000-2000 registrants and hundreds of people attending live online, from more than 100 countries.
Mr Peter May-Miller University Hospitals Plymouth
Mr Stuart McIntosh Queen's University Belfast
Stuart McIntosh is a Clinical Reader in Surgical Oncology at Queen’s University in Belfast, and an honorary consultant breast surgeon at Belfast City Hospital. He graduated from Edinburgh University in 1993, completing general surgical training in the North-East of Scotland, moving to Belfast in 2009, and to an academic position in 2015. He has been a consultant oncoplastic and reconstructive breast surgeon since 2005, with extensive clinical experience in the management of both breast cancer and benign breast conditions. He is an experienced breast cancer clinical trialist, having contributed to numerous trials in early breast cancer, with a particular emphasis on neoadjuvant, peri-surgical and treatment de-escalation studies. He is the Chief Investigator for the UK HTA-funded SMALL trial, a national phase III multicentre study comparing standard surgery with vacuum-assisted excision for the treatment of small screen-detected breast cancers. His translational research interests lie in the area of the DNA damage immune response in breast cancer. He is Chair of the UK National Cancer Research Institute Breast Research Group and a member of the NCRI Strategic Advisory Group, and he has an excellent overview of the portfolio of clinical and translational breast cancer research in the UK. In his role as the Royal College of Surgeons Breast Surgical Specialty Lead, he is responsible for supporting the development and delivery of breast cancer trials nationally, with a specific emphasis on surgical studies. In addition, he is also Clinical Director for the Northern Ireland Cancer Trials Network, responsible for overseeing delivery of cancer clinical research across the five cancer hospitals in Northern Ireland.
Miss Penny McManus Royal Lancaster Infirmary
Penny McManus has been a Consultant Breast Surgeon since 2004, initially in Hull & more recently in Morecambe Bay. She is best known for her work in Lipomodelling, she teaches on the Specialty Skills courses and also runs skills courses in Pakistan.
Dr Iain Macpherson Beatson West of Scotland Cancer Centre
Dr Iain Macpherson is a Clinical Senior Lecturer at the University of Glasgow and Honorary Consultant Medical Oncologist at the Beatson West of Scotland Cancer Centre, where he specialises in the treatment of breast cancer. He is Chief Investigator of the HER2-RADiCAL study, a co-CI of OPTIMA and a TMG member for numerous other clinical trials in breast cancer. He leads a pre-clinical research programme at the CRUK Beatson Institute investigating metabolic drivers of breast cancer progression. He is Clinical Lead for NHS Research Scotland (NRS) – West, Chair of the Scottish Cancer Trials Breast Group and Treasurer of the UK Breast Cancer Group. He trained in medicine at the University of Glasgow, graduating in 1998. He then completed a PhD at the Beatson Institute for Cancer Research and trained in Medical Oncology at the Beatson West of Scotland Cancer Centre.
Dr Penny Moyle Cambridge University Hospitals NHS Trust
Dr Penny Moyle graduated from Leicester University Medical School in 1997. After completing her Royal college of Physicians examinations, she entered radiology training initially in Liverpool but moved to Brisbane, Australia and subsequently Cambridge, obtaining her FRCR in 2005. She was appointed a Consultant Radiologist at Cambridge University Hospital in 2010, was Clinical Director of the Cambridge & Huntingdon Breast Screening Programme 2012- 2019 and Clinical Lead for the Cambridge Breast Unit 2013-2020. She currently is Clinical Lead for the Ultrasound Department at Cambridge University Hospital. Penny has an interest in education, teaching at a number of national courses, writing educational modules for the Royal Collage of Radiologists (RCR), book chapters and being a mentor for the RCR. His main clinical research interest is in breast cancer, being a Principal Investigator for two studies at Cambridge and has a peer review publication in breast and gynaecological imaging. She participates in peer reviews for four international journals.
Miss Michelle Mullan North Bristol NHS Trust
Michelle was appointed as a Consultant in Worcestershire in 2008, where she was Cancer Lead for the county. She subsequently relocated to Bristol in 2019 and is now Clinical Lead for Breast Services in North Bristol NHS Trust. She has been a Trustee for ABS since 2017. Michelle spent a year of her specialist registrar training in America, working at the Henry Ford Institute in Detroit and the University of Michigan, Ann Arbor. She was the MRC Almanac Fellow in Guildford and is the past recipient of the ESSO Breast Travelling Fellowship.
Mr Senthurun Mylvaganam Royal Wolverhampton Hospitals NHS Trust
Seni is an oncoplastic breast surgeon with a particular interest in surgical outcomes, quality assurance and training and education. He is a professional clinical advisor for surgery to the NHSBSP (Midlands and East) and ABS representative to the Sloane Project. He is the Chair of the Core Surgery Training and Advisory Committee and Chair of Core Surgery National Selection.
Dr Akriti Nanda Croydon University Hospital and Nuffield Department of Surgical Sciences, University of Oxford
Dr Samantha Ng University Hospital Wishaw, NHS Lanarkshire
Dr Samantha Nimalesena Royal Marsden Hospital
Dr Samantha Nimalesena is locum consultant in clinical oncology at the Royal Marsden Hospital in Sutton. She completed her specialist training in Kent and Canterbury, Guy's and St Thomas' and the Royal Marsden Hospitals.
Ms Maria Noblet
Miss Caroline Osborne Yeovil District Hospital and Dorset County Hospitals Foundation Trusts
Caroline works as Consultant Oncoplastic Breast Surgeon at Yeovil District Hospital and Dorset County Hospitals Foundation Trusts. A graduate of University College London, Caroline undertook a national oncoplastic TIG Fellowship in Newcastle and Salisbury prior to taking up her consultant post. She is Lead Cancer Clinician at YDH and has a particular interest in patient experience, cancer pathways and routes to diagnosis.
Professor Carlo Palmieri University of Liverpool
Carlo graduated in anatomy and medicine from the University of London, UK. Subsequently, undertaking his general medicine and medical oncology training in London. He successfully undertook a PhD at Imperial College London. He has been the recipient of a prestigious Cancer Research UK Clinician Scientist, and previously held the position of a senior lecturer within the department of Cancer at Imperial College London as well as being a Consultant in Medical Oncology at Imperial College Healthcare NHS Trust. He subsequent was appointed as a Professor of Translational Oncology and consultant medical oncologist at the University of Liverpool and The Clatterbridge Cancer Centre NHS Foundation Trust. His research interest are endocrine therapy and CNS disease and leads a number of translational studies in these areas. He co-leading the CCP-CANCER UK project which is characterising the outcomes of hospitalised cancer patients with COVID-19 who were recruited onto the UKs sleeping pandemic protocol. He is a member of the NCRI Breast Clinical Study Group and Chair of the advanced disease subgroup. As well as of the BIG working group on CNS disease and NHS England's Genomics Clinical Reference Group (CRG).
Dr Ann Partridge Harvard Medical School
Ann Partridge, MD, MPH is a Professor of Medicine at Harvard Medical School, and Vice Chair of Medical Oncology at Dana-Farber Cancer Institute, where she also serves as Director of the Adult Survivorship Program and leads the Program for Young Women with Breast Cancer. As a medical oncologist and clinical researcher, she has sought to improve the care and outcomes of patients with cancer by conducting research, and by developing innovative clinical programming. Dr. Partridge serves in leadership roles nationally and internationally including as co-chair of the Breast Committee of the Alliance for Clinical Trials in Oncology and co-chair of the biennial ESMO-ESO sponsored Breast Cancer in Young Women Conference. She also served as Chair of the Center for Disease Control and Prevention (CDC) Advisory Committee on Breast Cancer in Young Women from 2010-17. She has received prior awards and grants including a Champions of Change award from the White House, an ASCO Improving Cancer Care Grant, the CDC Carol Friedman Award, the American Association for Cancer Research (AACR) Outstanding Investigator Award for Breast Cancer, and the Ellen L. Stovall Award in Cancer Survivorship from ASCO, and the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School. After graduating from Georgetown University, Dr. Partridge received her medical degree from Cornell University Medical College, pursued an internal medicine residency at the Hospital for the University of Pennsylvania, and completed Medical Oncology and Hematology fellowship at Dana-Farber/Partners CancerCare. She earned a Master of Public Health degree at the Harvard School of Public Health.
Mr Vassilis Pitsinis NHS Tayside
Vassilis Pitsinis MD, PhD, FRCS (Eng.), EBSQ is a consultant breast surgeon in NHS Tayside in Scotland (Ninewells Hospital and Medical School) with an interest in Oncoplastic Surgery. He is also an Honorary Senior Clinical Lecturer in the University of Dundee Medical School. Following his graduation from medical School he completed his MD thesis in experimental surgery in the University of Athens medical School in 2004. His surgical training took place in London and in East Anglia as well as in the University Hospitals in Athens and Strasbourg's Louis Pasteur University in France. He has completed a breast surgical fellowship in Cambridge and in Paris. His current research into breast cancer is focused on in replacing radioisotope and blue dye with fluorescence as localisation for sentinel lymph node biopsy in early breast cancer. He has been elected as a Tayside Academic Health Science Partnership Clinical Fellow.
Miss Shelley Potter North Bristol NHS Trust and Bristol Medical School
Shelley Potter is an Associate Professor of Oncoplastic Breast Surgery at Bristol Medical School and Consultant Oncoplastic Breast Surgeon at North Bristol NHS Trust. Her research interests focus on improving outcomes for women undergoing oncoplastic and reconstructive breast surgery by generating high quality evidence to support clinical practice and decision-making. She is currently Chief Investigator of the Pre-BRA, ANTHEM, Brighter and Best-BRA studies, Chair of the iBRA-NET group and Secretary to the ABS Academic and Research Committee.
Mrs Simerjit Rai Birmingham City Hospital, Sandwell and West Birmingham Hospitals NHS Trust
MSc, BSc (hons), Dip HE, RN, NMP, SCP Mrs Rai's career in the NHS started in 1991, Since then she has worked in the field of medicine, surgery, gynae, GU, district and practice nursing. She has worked both within primary and secondary care. She currently works within the breast team at City Hospital in Birmingham starting as a Surgical Care Practitioner (16 years ago) progressing to her current title of Nurse Consultant. During her time in the breast team she has been in the forefront of new initiatives, these include day case breast surgery commenced in 2007, Patient initiated follow-up commenced in 2010, and recently Virtual 5 Year MDT in Jan 2020.
Mr Ahsan Rao Broomfield Hospital
BSc (hons) from University of Toronto. Mr Rao moved to Scotland to do medicine at the University of Aberdeen. Mr Rao got his surgical training from East of England deanery. During that time, he took a break to complete his PhD in Surgery and public health from Imperial College London. He is due to start his TIG fellowship at BARTS, London. Mr Rao's research interests include systematic reviews, Cochrane Reviews, big data analysis and digital health pathways.
Miss Kathryn Rigby Doncaster & Bassetlaw Teaching Hospitals NHS Foundation Trust
MBChB FRCS MSc FRCS (General Surgery) Consultant Oncoplastic Breast Surgeon Doncaster & Bassetlaw Teaching Hospitals NHS FT. Clinical Director for GI Surgery, Vascular, Urology & Breast Surgery. Honorary Senior Clinical Lecturer – Academic Unit of Medicine, Sheffield University. Phase Lead Undergraduate Medicine – Academic Unit of Medicine, Sheffield University. Clinical Practice & Standards Committee Member of ABS, Regional. Representative Yorkshire & Humber. National Bulletins Production for the CPSC meetings. Ongoing Guidance Development for ABS. Examiner for Intercollegiate FRCS. Leeds Medical School. Training Rotations, Nottingham & Sheffield regions. TIG Fellowship Birmingham. Active Academic, Education and Research Interests.
Mr Laszlo Romics Gartnavel Hospital, NHS Greater Glasgow and Clyde
Laszlo Romics graduated at Semmelweis University, Hungary in 1995. He completed surgical training at the same university, followed by a research fellowship at the University of Massachusetts between 2001 - 2003. Laszlo continued his surgical training at the Cork University hospital until 2006, and then he undertook an oncoplastic fellowship at the Glasgow Royal Infirmary. Laszlo is a consultant at the Greater Glasgow and Clyde Health Board since 2007. Currently he is the member of the Academic and Research Committee and Clinical Advisor for Scotland at the Screening Committee at ABS.
Dr Brogan Rudge
Professor Peter Schmid Bart's Cancer Institute
Professor Schmid is internationally recognized for his research and education leadership in breast cancer. He is the clinical director of the Breast Cancer Centre and an honorary consultant medical oncologist at St. Bartholomew’s Hospital. He was appointed in 2013 as Chair in Cancer Medicine at Barts Cancer Institute (BCI), Queen Mary University, London. Professor Schmid is also Lead of the Centre of Experimental Cancer Medicine at Barts Cancer Institute, overseeing the conduct of early phase trials at St. Bartholomew’s Hospital and BCI, with a particular interest in Immunotherapy, innovative trial designs, and circulating biomarkers. He leads the academic breast cancer programme at St. Bartholomew’s Hospital and BCI. Prof Schmid graduated from the Technical University of Munich medical school in 1997, gaining a MD in Clinical Chemistry in 1998 from the University of Munich and a Clinical Research PhD in 2005 from Charité University in Berlin. He trained at the University Hospital Charité in Berlin in internal medicine, haematology, and oncology, before he became a Senior Clinical Lecturer and Director of the Hammersmith Early Clinical Trials Unit at Imperial College London in 2005. Professor Schmid was appointed as Foundation Chair in Cancer Medicine at the University of Sussex in 2010 before taking on his current role at BCI in 2013. Professor Schmid’s primary research interest is in clinical research in breast cancer with the goal of improving the treatment of women with breast cancer by defining more effective and less toxic approaches. Specific research areas include cancer immune therapy, triple-negative breast cancer, endocrine resistance, and innovative biomarker-driven trial concepts. Professor Schmid runs an international collaborative clinical and translational research programme. Professor Schmid is the principal investigator of several pivotal breast cancer studies, including the Impassion130 trial that evaluated atezolizumab for advanced triple-negative breast cancer and led to the regulatory approval of the first immunotherapy strategy for patients with breast cancer, establishing a new standard of care of this disease. Professor Schmid is also the lead investigator of the KEYNOTE-522 trial which evaluated the immune-checkpoint inhibitor Pembrolizumab in combination with neoadjuvant chemotherapy for early triple-negative breast cancer and demonstrated a significant increase in pathological response rates. His work has been published in many journals including the New England Journal of Medicine, Lancet, Lancet Oncology, JAMA Oncology, Nature Communications and the Journal of Clinical Oncology. Prof Schmid is a member of several national and international cancer organisations and research groups and has been involved in international consensus meetings on the management of breast cancer. Professor Peter Schmid is a member of the European Society for Medical Oncology (ESMO) breast cancer faculty.
Dr Bhupinder Sharma The Royal Marsden Hospital & The Institute of Cancer Research, UK
Dr Bhupinder Sharma BSc (Hons) BM FRCR is a Clinical & Active Research Consultant Radiologist at The Royal Marsden Hospital and The Institute of Cancer Research, London & Sutton UK, & Expert Advisor to the UK NICE Centre for Guidelines Development (CfG). Dr Sharma has authored numerous UK National Guidelines, has >180 publications, including multiple first & senior author Nature journals & Haemato-oncology journal global original publications and numerous book chapters. Current areas of active research include BIA-ALCL, Dr Sharma having numerous original BIA-ALCL publications, also being an invited co-author for the UK MHRA PRASEAG BIA-ALCL Guidelines, with recent senior author American Society of Haematology, RSNA, and American Society of Clinical Oncology conference publications. Dr Sharma is PET and radiology imaging lead for multiple specialist MDTMs, including PET lead for the RMH specialist breast MDTM.
Dr Nisha Sharma Leeds Teaching Hospital NHS Trust
Dr Sharma is a consultant breast radiologist and Director of the Breast Screening program Leeds/Wakefield. She is active in research involving new technologies, artificial intelligence and improving the patient pathway. She is a professional clinical advisor for breast screening and NHS England.
Professor Linda Sharp Newcastle University
Linda Sharp is Professor of Cancer Epidemiology at Newcastle University. For the past 15 years, she has been leading research studies in the area of cancer survivorship. Her interests include: symptom burden and psychological wellbeing; financial impact of cancer; unmet supportive care needs; potential for supported self-management; and the development and testing of interventions to support cancer survivors. Around 10 years ago she developed an interest in adherence to endocrine therapy in breast cancer and was involved in a series of studies which examined patterns of adherence and factors associated with adherence. She is currently co-leading the NIHR-funded SWEET research programme which is developing and testing an intervention to support women with early breast cancer to adhere to endocrine therapy.
Mr Mark Sibbering University Hospitals of Derby and Burton
Mark Sibbering has been a Consultant Surgeon at Derby since 1997. He is a past President of the Association of Breast Surgery (2017-19). He is Lead Clinician for the Derbyshire Community Breast Pain Clinic Pilot.
Dr Richard Sidebottom The Royal Marsden Hospital
Richard is a radiology consultant at Cheltenham and at The Royal Marsden hospitals where he is part of the artificial intelligence imaging hub. He has a MSc in biomedical engineering and is interested in the future development of imaging technologies.
Miss Jo Skillman University Hospital Coventry & Warwickshire
Jo Skillman is a plastic surgeon who trained in Oxford, London, Sydney and completed an oncoplastic breast and an aesthetic fellowship. She has been a fully accredited specialist in plastic surgery since 2009 and is member of the British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS). In addition to clinical work, she is also a trainer on the oncoplastic skills course and the Master's in oncoplastic surgery. She has published more than 30 articles on all types of cosmetic and plastic surgery. She has co-written the National Lipomodelling Guidelines, which sets quality standards in the UK. She is currently an NHS consultant in plastic surgery at a University Hospital in Coventry and Warwickshire specialising in reconstruction for people with injuries and breast and skin cancer.
Mr Edward St John Portsmouth Hospitals University NHS Trust
Mr Edward St John is a consultant oncoplastic breast surgeon working at Portsmouth Hospitals University NHS Trust and the Portsmouth Technologies Trials Unit (PTTU). He is passionate about healthcare and effective, safe innovation. He is Chair of the iBRA-NET Innovation Group (allied with the Association of Breast Surgery and British Association of Plastic, Reconstructive and Aesthetic Surgeons), who's mission is to identify, evaluate and translate useful innovations into breast surgical practice. He is also an NHS clinical entrepreneur fellow & Co-founder of Concentric Health, an InnovateUK & SBRI supported platform for digital consent & enhanced shared decision making. Amongst other skills he has domain expertise in consent & shared decision making, the evaluation of medical devices and digital health.
Ms CJ Tollan Royal Marsden Hospital
CJ Tollan is currently the Oncoplastic Breast TIG fellow at the Royal Marsden Hospital. She completed her training in Plastic Surgery in Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary, where she is due to start her Consultant Plastic Surgeon post later this year.
Professor Clare Turnbull Institute of Cancer Research
Clare is a clinical consultant in Cancer Genetics and a Professor of Translational Cancer Genetics in the Division of Genetics and Epidemiology at the Institute of Cancer Research. Her research spans statistical, population and public-health-related analyses of cancer epidemiology, genetic cancer susceptibility and implementation of expanded genomic testing. She is currently leading a £4.3 million CRUK-funded Catalyst Award: ‘CanGene-CanVar: Data Resources, Clinical and Educational Tools to leverage Cancer Susceptibility Genetics for Early Detection and Prevention of Cancer’ program, involving analysis of national genomic datasets against PHE National Cancer Registration datasets with a strong focus on variant interpretation. She also leads BRCA-DIRECT: a CRUK-funded program to develop and pilot a digital platform to deliver BRCA testing, enabling extension of testing to all women with breast cancer.
Professor Andrew Tutt The Institute of Cancer Research
Andrew Tutt qualified in Medicine in 1990. After completing postgraduate training in General Medicine, he trained in Clinical Oncology at the Royal Marsden Hospital, before gaining a Predoctoral Research Training Fellowship from the Medical Research Council to work in Professor Alan Ashworth’s laboratory, at The Institute of Cancer Research. There he worked on the then unknown DNA repair functions of the BRCA2 breast cancer predisposition gene, and described the role of BRCA2 in homologous recombination (HR). He was awarded his PhD in 2002. In his postdoctoral work as a Clinician Scientist, he identified the synthetic lethality between PARP inhibitors and BRCA1/2 mutations with Dr Chris Lord and Professor Alan Ashworth. He went on to design the single agent PARP inhibitor Proof of Concept Phase I trials and associated DNA repair biomarker studies with the ICR and Royal Marsden Drug Development Unit, and has since led international Phase II and III trials, examining the role of HR directed therapies, including PARP inhibitors and platinums for BRCA1 / BRCA2 deficiency associated malignancy including; the OlympiA and TNT trials, which have changed clinical practice guidelines for patients with BRCA1 and BRCA2 mutated breast cancer. He cares for women with breast cancer as a Consultant Oncologist, and as a member of the multidisciplinary Breast Units at Guy’s and St Thomas’ and Royal Marsden NHS Foundation Trusts. Andrew has been a member of the St Gallen Early Breast Cancer International Consensus Panel, the Oxford Early Breast Cancer Trialists Cooperative Group (EBCTCG) and Vice Chair of CRUK Experimental Medicine Expert Review Panel. He is a member of ESMO Breast Cancer Guidelines and serves on the ESMO Scientific Committees shaping the programmes for both ESMO Breast 2022 and ESMO 2023 congresses. He is Director of the Breast Cancer Now Toby Robins Research Centre at The Institute of Cancer Research (ICR) and the Breast Cancer Now Research Unit at King’s College London (KCL). He is Head of the Division of Breast Cancer Research and Professor of Breast Oncology at the ICR and a Professor of Clinical Oncology at KCL. Andrew leads a clinical trial programme focusing on TNBC and cancers associated with functional deficiencies in BRCA1 and BRCA2. He also leads translational laboratories at both the ICR and KCL, studying BRCA1 and BRCA2 associated and Triple Negative forms of breast cancer (TNBC). His ICR laboratory is joint with biologist colleague Professor Christopher Lord. In 2015 he received the Addarii Award from the University of Bologna for his work in the field of BRCA1 and BRCA2 associated breast and ovarian cancer research. In 2019 Andrew was elected to the Fellowship of the Academy of Medical Sciences and most recently was awarded the ESMO Breast Cancer Award 2021.
Mr Joseph Ward The Royal Marsden NHS Foundation Trust
Ms Ruth Waters University Hospital Birmingham
Professor Eila Watson Oxford Brookes University
Eila Watson is Professor of Supportive Cancer Care and Deputy Director of the Oxford Institute of Nursing, Midwifery and Allied Health Research at Oxford Brookes University. She is also an Advisor with the NIHR Research Design Service (South Central). Eila is a health services researcher with over 20 years experience. Her current research focuses on understanding the impact of cancer and its treatment on individuals and their families, and developing and trialling interventions to address areas of unmet need. She is also an experienced PhD supervisor, and post-graduate research tutor. Eila is a member of the National Cancer Research Institute Living With and Beyond Cancer Group, and the Yorkshire Cancer Research Scientific Advisory Board. She is a past member of the NIHR RfPB panel (Oxford) and Tenovus Advisory panel, and is past president of the British Psychosocial Oncology Society.
Dr Stephanie Wong Jewish General Hospital Segal Cancer Centre, McGill University
Stephanie Wong, MD MPH is an assistant professor of surgery at McGill Medical School and a breast surgical oncologist at the JGH Segal Cancer Centre in Montreal, Canada. She received her medical degree and completed general surgery residency at McGill University, her MPH at the Harvard School of Public Health, and in 2019, completed her breast surgical oncology fellowship at Dana-Farber/Brigham and Women’s Cancer Centre and Massachusetts General Hospital in Boston. Her clinical and research interests focus on surgical outcomes following neoadjuvant treatment and high-risk patient populations. She directs the High Risk Breast Clinic at the JGH Stroll Cancer Prevention Centre and in 2021 was recipient of the FRQS Clinical Research Scholars award for research on Optimizing Surgical Decision Making and Prevention Strategies for Women at Elevated Breast Cancer Risk.